{"id":8247,"date":"2025-05-02T17:49:32","date_gmt":"2025-05-02T09:49:32","guid":{"rendered":"https:\/\/regask.com\/?page_id=8247"},"modified":"2025-05-05T10:15:36","modified_gmt":"2025-05-05T02:15:36","slug":"raps-convergencia-euro-2025","status":"publish","type":"page","link":"https:\/\/regask.com\/es\/raps-euro-convergence-2025\/","title":{"rendered":"RAPS Convergencia Europea 2025"},"content":{"rendered":"<div id=\"gap-673396827\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-673396827 {\n  padding-top: 90px;\n}\n<\/style>\n\t<\/div>\n\t\n\n\t<section class=\"section\" id=\"section_1015924777\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/06\/Careers-header-bg.svg\" class=\"bg attachment-medium_large size-medium_large\" alt=\"Encabezado de Carreras Bg\" \/>\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row row-large align-middle\"  id=\"row-1960986246\">\n\n\t<div id=\"col-465523789\" class=\"col medium-5 small-12 large-5\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"img has-hover no-margin x md-x lg-x y md-y lg-y\" id=\"image_896066724\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"720\" height=\"720\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png\" class=\"attachment-medium_large size-medium_large\" alt=\"Regask rapea\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png 720w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS-330x330.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS-12x12.png 12w\" sizes=\"auto, (max-width: 720px) 100vw, 720px\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_896066724 {\n  width: 90%;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-465523789 > .col-inner {\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1866996173\" class=\"col medium-6 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h5><span style=\"font-size: 95%;\" data-text-color=\"secondary\">PATROCINADORES DE REGASK<\/span><\/h5>\n<h1><span style=\"font-size: 90%;\">RAPS Convergencia Europea 2025<\/span><\/h1>\n<div class=\"is-divider divider clearfix\" style=\"max-width:40px;background-color:rgb(145, 138, 215);\"><\/div>\n\t<div id=\"text-3657077934\" class=\"text\">\n\t\t\n<p data-line-height=\"s\"><span data-text-color=\"primary\"><strong>13-16 DE MAYO DE 2025 | BRUSELAS, B\u00c9LGICA<\/strong><\/span><\/p>\n<p data-line-height=\"s\"><span data-text-color=\"primary\"><strong>Centro de Convenciones Square Brussels, Stand n.\u00ba 3<\/strong><\/span><\/p>\n\t\t\n<style>\n#text-3657077934 {\n  text-align: left;\n  color: rgb(227, 227, 227);\n}\n#text-3657077934 > * {\n  color: rgb(227, 227, 227);\n}\n<\/style>\n\t<\/div>\n\t\n<a href=\"https:\/\/regask.com\/es\/raps-convergencia-euro-2025\/#register20\" class=\"button secondary\" >\n\t\t<span>\u00a1Nos vemos en RAPS Euro Convergence 2025!<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1015924777 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n}\n@media (min-width:550px) {\n  #section_1015924777 {\n    padding-top: 60px;\n    padding-bottom: 60px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\n<span class=\"scroll-to\" data-label=\"Scroll to: #register20\" data-bullet=\"false\" data-link=\"#register20\" data-title=\"Register\"><a name=\"register20\"><\/a><\/span>\n<div class=\"row row-collapse row-full-width\"  id=\"row-491625934\">\n\n\t<div id=\"col-2004719190\" class=\"col medium-12 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\n\t<section class=\"section dark\" id=\"section_1645564787\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-center\"  id=\"row-594444045\">\n\n\t<div id=\"col-417360222\" class=\"col medium-8 small-12 large-8\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"text-736091442\" class=\"text\">\n\t\t\n<h3>Conozca a nuestro equipo<\/h3>\n\t\t\n<style>\n#text-736091442 {\n  font-size: 1.5rem;\n  text-align: left;\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"gap-124494660\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-124494660 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-1619843420\" class=\"text\">\n\t\t\n<p class=\"p1\"><span style=\"font-size: 90%;\">Unirse<span class=\"s1\">, <span class=\"s1\"><b>Yasmine Fathallah<\/b><\/span>, y <span class=\"s1\"><b>Ilkka Howard<\/b><\/span> en el stand RegASK para explorar c\u00f3mo nuestra inteligencia regulatoria impulsada por IA est\u00e1 transformando las estrategias de cumplimiento.<\/span><\/span><\/p>\n<p><span style=\"font-size: 90%;\">Aprenda m\u00e1s con ellos sobre \u2013 <\/span><\/p>\n<ul>\n<li><span style=\"font-size: 90%;\">El papel revolucionario de la IA en la inteligencia regulatoria<\/span><\/li>\n<li><span style=\"font-size: 90%;\">C\u00f3mo la tecnolog\u00eda de vanguardia de RegASK est\u00e1 agilizando los flujos de trabajo regulatorios<\/span><\/li>\n<li><span style=\"font-size: 90%;\">C\u00f3mo nuestras soluciones impulsadas por IA pueden ayudar a su organizaci\u00f3n a mantenerse a la vanguardia de las cambiantes regulaciones globales.<\/span><\/li>\n<\/ul>\n\t\t\n<style>\n#text-1619843420 {\n  text-align: left;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-417360222 > .col-inner {\n  margin: 0px 40px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row align-center\"  id=\"row-957183242\">\n\n\t<div id=\"col-2064452540\" class=\"col medium-9 small-12 large-9\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"box has-hover   has-hover box-default box-text-bottom\" >\n\n\t\t<div class=\"box-image\" >\n\t\t\t\t\t\t<div class=\"\" >\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"979\" height=\"401\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/05\/RAPS-Euro-Convergence-attendees-v2.png\" class=\"attachment- size-\" alt=\"Asistentes a la Convergencia Europea de Raps V2\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/05\/RAPS-Euro-Convergence-attendees-v2.png 979w, https:\/\/regask.com\/wp-content\/uploads\/2025\/05\/RAPS-Euro-Convergence-attendees-v2-330x135.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/05\/RAPS-Euro-Convergence-attendees-v2-18x7.png 18w\" sizes=\"auto, (max-width: 979px) 100vw, 979px\" \/>\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\t<div class=\"box-text text-center is-small\" >\n\t\t\t<div class=\"box-text-inner\">\n\t\t\t\t\n\t<div id=\"gap-2007800984\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2007800984 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<div class=\"row align-center\"  id=\"row-1136019534\">\n\n\t<div id=\"col-117602258\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<p><span style=\"font-size: 100%;\"><strong>Yasmine Fathallah<\/strong><\/span><\/p>\n<p>Gerente de soluciones para clientes<\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-1695555763\" class=\"col medium-1 small-12 large-1\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-1683242720\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<p><span style=\"font-size: 100%;\"><strong>Ilkka Howard<\/strong><\/span><\/p>\n<p>Director de Cuentas de Desarrollo de Negocios<\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\t<div id=\"gap-1577778636\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1577778636 {\n  padding-top: 0px;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1645564787 {\n  padding-top: 70px;\n  padding-bottom: 70px;\n  min-height: 900px;\n  background-color: rgb(10, 35, 66);\n}\n@media (min-width:550px) {\n  #section_1645564787 {\n    padding-top: 20px;\n    padding-bottom: 20px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-71563350\" class=\"col medium-12 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\n\t<section class=\"section dark\" id=\"section_336549058\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-center\"  id=\"row-201922332\">\n\n\t<div id=\"col-1094384944\" class=\"col medium-10 small-12 large-10\"  data-animate=\"fadeInRight\">\n\t\t\t\t<div class=\"col-inner text-center box-shadow-2\" style=\"background-color:rgb(255, 255, 255);\" >\n\t\t\t\n\t\t\t\n\n<p><script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/embed\/v2.js\"><\/script><br \/>\n<script>\n  hbspt.forms.create({\n    portalId: \"20908020\",\n    formId: \"cf433518-1c2a-4d74-815a-a83d4de7893e\",\n    region: \"na1\"\n  });\n<\/script><br \/>\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1094384944 > .col-inner {\n  padding: 30px 30px 30px 30px;\n  border-radius: 16px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_336549058 {\n  padding-top: 70px;\n  padding-bottom: 70px;\n  min-height: 900px;\n  background-color: rgb(251, 250, 254);\n}\n@media (min-width:550px) {\n  #section_336549058 {\n    padding-top: 0px;\n    padding-bottom: 0px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\n\t<section class=\"section\" id=\"section_1892171053\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t<img decoding=\"async\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/bg-flip-card-1.svg\" class=\"bg attachment- size-\" alt=\"Tarjeta de visita 1 de Bg\" \/>\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row\"  id=\"row-602093505\">\n\n\t<div id=\"col-515847660\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-1736406336\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1736406336 {\n  padding-top: 40px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>RAPS Convergencia Europea 2025<\/h2>\n\t<div id=\"text-2752115278\" class=\"text\">\n\t\t\n<p>RAPS Euro Convergence es la conferencia sobre asuntos regulatorios m\u00e1s completa de Europa, centrada en los \u00faltimos temas y desarrollos en productos de atenci\u00f3n m\u00e9dica en Europa y m\u00e1s all\u00e1, con sesiones en dispositivos m\u00e9dicos, IVD, productos farmac\u00e9uticos, productos combinados, negocios regulatorios, IA, software y ciberseguridad.<\/p>\n<p>RAPS Euro Convergence re\u00fane a profesionales de asuntos regulatorios y socios de la industria para compartir y colaborar en soluciones para la mejora y el avance de la atenci\u00f3n m\u00e9dica en Europa.<\/p>\n<h3><span style=\"font-size: 85%;\">Razones para asistir<\/span><\/h3>\n<ul>\n<li>Acceda a contenido seleccionado por expertos regulatorios de alto nivel de la UE y autoridades sanitarias destacadas.<\/li>\n<li>Con\u00e9ctese con proveedores de soluciones globales y de la UE sobre las \u00faltimas innovaciones.<\/li>\n<li>Experimente conocimientos, perspectivas e intercambios integrales con l\u00edderes globales para acelerar hojas de ruta pr\u00e1cticas e inteligentes para su organizaci\u00f3n.<\/li>\n<\/ul>\n<h3><span style=\"font-size: 85%;\">Programa RAPS Euro Convergencia 2025<\/span><\/h3>\n<p>RAPS Euro Convergence proporciona conocimientos esenciales en las industrias de dispositivos m\u00e9dicos, IVD y farmac\u00e9utica, que lo preparar\u00e1n para navegar con \u00e9xito en el panorama regulatorio de la UE.<\/p>\n<h3><span style=\"font-size: 85%;\">Transformar el entorno regulatorio europeo a trav\u00e9s de la innovaci\u00f3n colaborativa<\/span><\/h3>\n<p>La profesi\u00f3n de asuntos regulatorios en Europa ha logrado grandes avances en el sector sanitario europeo. Con tanto progreso, \u00bfc\u00f3mo puede Europa mantener su posici\u00f3n global y competitividad en los pr\u00f3ximos a\u00f1os? La comunidad de asuntos regulatorios se reunir\u00e1 en Bruselas, B\u00e9lgica, del 13 al 16 de mayo para profundizar en el aprendizaje y los debates, centr\u00e1ndose en la innovaci\u00f3n, la sostenibilidad, la resiliencia y la transformaci\u00f3n din\u00e1mica, con el objetivo de posicionar a Europa como una regi\u00f3n l\u00edder en regulaci\u00f3n sanitaria.<br \/>\n\t\t\n<style>\n#text-2752115278 {\n  text-align: left;\n  color: rgb(17, 59, 111);\n}\n#text-2752115278 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n<a href=\"https:\/\/regask.com\/es\/conferencia-de-rap-2025\/#register20\" class=\"button secondary\" >\n\t\t<span>\u00a1Nos vemos en RAPS Euro Convergence 2025!<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1892171053 {\n  padding-top: 60px;\n  padding-bottom: 60px;\n  background-color: rgb(255, 255, 255);\n}\n<\/style>\n\t<\/section>\n\t\n\n\t<section class=\"section\" id=\"section_525047905\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-equal align-center\"  id=\"row-1413477416\">\n\n\t<div id=\"col-1488578262\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Nuestra soluci\u00f3n<\/h2>\n<p>RegASK aprovecha la inteligencia artificial avanzada y el aprendizaje autom\u00e1tico para ayudar a las empresas de sectores altamente regulados a optimizar sus procesos de cumplimiento normativo y mantenerse a la vanguardia. Nuestra soluci\u00f3n de vanguardia automatiza la investigaci\u00f3n regulatoria, brinda informaci\u00f3n vital y permite que los equipos de asuntos regulatorios se conviertan en socios estrat\u00e9gicos para impulsar el crecimiento empresarial.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1488578262 > .col-inner {\n  padding: 0px 0px 0px 0px;\n}\n@media (min-width:550px) {\n  #col-1488578262 > .col-inner {\n    padding: 0px 50px 0px 50px;\n  }\n}\n@media (min-width:850px) {\n  #col-1488578262 > .col-inner {\n    padding: 0px 170px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-307747718\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/RegGenius-Product-Icon-2.svg\" class=\"attachment-medium size-medium\" alt=\"Icono de producto Reggenius (2)\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-362812227\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">RegGenius<\/h4>\n\t\t\n<style>\n#text-362812227 {\n  color: rgb(10, 35, 66);\n}\n#text-362812227 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-2846111840\" class=\"text\">\n\t\t\n<p>Aproveche el poder de la IA para obtener una ventaja competitiva en el cumplimiento normativo.<br \/>\n\t\t\n<style>\n#text-2846111840 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-2846111840 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-307747718 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1359581222\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/Alerts-icon.svg\" class=\"attachment-medium size-medium\" alt=\"Icono de alertas\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-1686222717\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">Alerta de registro<\/h4>\n\t\t\n<style>\n#text-1686222717 {\n  color: rgb(10, 35, 66);\n}\n#text-1686222717 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-1118377377\" class=\"text\">\n\t\t\n<p>Sin sorpresas con el monitoreo regulatorio automatizado.<br \/>\n\t\t\n<style>\n#text-1118377377 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-1118377377 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1359581222 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-492235668\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/Data-Driven-Excellence-icon.svg\" class=\"attachment-medium size-medium\" alt=\"Icono de excelencia basada en datos\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-3193597224\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">RegInsights<\/h4>\n\t\t\n<style>\n#text-3193597224 {\n  color: rgb(10, 35, 66);\n}\n#text-3193597224 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-4075433333\" class=\"text\">\n\t\t\n<p>Identifique tendencias, anticipe riesgos y construya mejores estrategias.<br \/>\n\t\t\n<style>\n#text-4075433333 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-4075433333 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-492235668 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-954959098\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/AskRegASK-Product-Icon.svg\" class=\"attachment-medium size-medium\" alt=\"Icono del producto AskRegASK\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-1383385860\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">Ask RegASK<\/h4>\n\t\t\n<style>\n#text-1383385860 {\n  color: rgb(10, 35, 66);\n}\n#text-1383385860 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-2801834205\" class=\"text\">\n\t\t\n<p>Acceso a nuestra comunidad de expertos en temas regulatorios.<br \/>\n\t\t\n<style>\n#text-2801834205 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-2801834205 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-954959098 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 30px 0px;\n  border-radius: 30px;\n}\n@media (min-width:550px) {\n  #col-954959098 > .col-inner {\n    margin: 0px 0px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_525047905 {\n  padding-top: 0px;\n  padding-bottom: 0px;\n  background-color: rgb(250, 250, 250);\n}\n@media (min-width:550px) {\n  #section_525047905 {\n    padding-top: 60px;\n    padding-bottom: 60px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\n\t<section class=\"section\" id=\"section_1382188671\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-center\"  id=\"row-122508320\">\n\n\t<div id=\"col-1770984386\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n<h2>Recursos<\/h2>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1770984386 > .col-inner {\n  padding: 50px 0px 0px 0px;\n  margin: 30px 0px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1787608320\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n  \n    <div class=\"row eneko-case-studies radius-30 large-columns-3 medium-columns-2 small-columns-1 slider row-slider slider-nav-simple slider-nav-outside slider-nav-push\"  data-flickity-options='{&quot;imagesLoaded&quot;: true, &quot;groupCells&quot;: &quot;100%&quot;, &quot;dragThreshold&quot; : 5, &quot;cellAlign&quot;: &quot;left&quot;,&quot;wrapAround&quot;: true,&quot;prevNextButtons&quot;: true,&quot;percentPosition&quot;: true,&quot;pageDots&quot;: true, &quot;rightToLeft&quot;: false, &quot;autoPlay&quot; : false}' >\n\n  <div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-government-shutdown-life-sciences-impact\/\" class=\"plain\" aria-label=\"Gestionando un posible cierre del gobierno de EE. UU.: Implica\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector.jpg\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"An\u00e1lisis de las posibles implicaciones del cierre del gobierno estadounidense para el sector de las ciencias biol\u00f3gicas\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector.jpg 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector-330x248.jpg 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector-16x12.jpg 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">11 de marzo de 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/blogs\/\">Blogs<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-government-shutdown-life-sciences-impact\/\" class=\"plain\">Gestionando un posible cierre del gobierno de EE. UU.: Implica\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tMientras los legisladores en Washington, DC, enfrentan una fecha l\u00edmite cr\u00edtica del 14 de marzo para finalizar el gasto federal, la posibilidad de un cambio de gobierno en EE.UU.\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-government-shutdown-life-sciences-impact\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/blogs\/\" class=\"category-blogs\">Blogs<\/a> <a href=\"https:\/\/regask.com\/es\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Estados Unidos<\/a> <a href=\"https:\/\/regask.com\/es\/category\/blogs\/pharma-and-biotech-news\/\" class=\"category-pharma-and-biotech-news\">Farmacia y biotecnolog\u00eda<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/2024-gartner-feature\/\" class=\"plain\" aria-label=\"RegASK aparece en la Gu\u00eda de mercado de Gartner para la regulaci\u00f3n\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner.jpg\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Regask, gu\u00eda de mercado reconocida por Gartner\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner.jpg 800w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner-330x248.jpg 330w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner-16x12.jpg 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">21 de noviembre de 2024 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/company-news\/\">Noticias de la empresa<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/2024-gartner-feature\/\" class=\"plain\">RegASK aparece en la Gu\u00eda de mercado de Gartner para la regulaci\u00f3n\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\t\u00a1Nos complace anunciar que RegASK ha sido incluido en la Gu\u00eda de mercado de Gartner para soluciones de inteligencia regulatoria! Este reconocimiento\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/2024-gartner-feature\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/company-news\/\" class=\"category-company-news\">Noticias de la empresa<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/the-2025-state-of-regulatory-affairs-and-compliance-report\/\" class=\"plain\" aria-label=\"Informe sobre el estado de los asuntos regulatorios y el cumplimiento en 2025\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Imagen destacada del sitio web 800 600\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">15 de noviembre de 2024 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/reports\/\">Informes<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/the-2025-state-of-regulatory-affairs-and-compliance-report\/\" class=\"plain\">Informe sobre el estado de los asuntos regulatorios y el cumplimiento en 2025<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\t\u00bfEst\u00e1 su organizaci\u00f3n preparada para las complejidades regulatorias de 2025? El panorama regulatorio en 2025 es m\u00e1s complejo que nunca, con nuevas adv\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/the-2025-state-of-regulatory-affairs-and-compliance-report\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/reports\/\" class=\"category-reports\">Informes<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/doge-fda-lease-cancellations\/\" class=\"plain\" aria-label=\"DOGE afirma haber ahorrado $30M al cancelar 30 contratos de arrendamiento de la FDA\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Doge anuncia un ahorro de 30 millones al cancelar 30 contratos de arrendamiento de la FDA\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">7 de marzo de 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/news\/\">Noticias regulatorias<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/doge-fda-lease-cancellations\/\" class=\"plain\">DOGE afirma haber ahorrado $30M al cancelar 30 contratos de arrendamiento de la FDA<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/doge-fda-lease-cancellations\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Estados Unidos<\/a> <a href=\"https:\/\/regask.com\/es\/category\/news\/\" class=\"category-news\">Noticias regulatorias<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/france-ansm-ce-mark-exemption\/\" class=\"plain\" aria-label=\"ANSM (Francia) aclara el proceso de exenci\u00f3n de la marca CE para M...\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Ansm France aclara el proceso de exenci\u00f3n de la marca CE para dispositivos m\u00e9dicos\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">26 de febrero de 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/news\/\">Noticias regulatorias<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/france-ansm-ce-mark-exemption\/\" class=\"plain\">ANSM (Francia) aclara el proceso de exenci\u00f3n de la marca CE para M...<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tEl 27 de enero de 2025, la Agencia Nacional de Seguridad de Medicamentos y Productos Sanitarios (ANSM) de Francia emiti\u00f3 una actualizaci\u00f3n clave sobre el proces\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/france-ansm-ce-mark-exemption\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/region\/europe\/france-regulations\/\" class=\"category-france-regulations\">Francia<\/a> <a href=\"https:\/\/regask.com\/es\/category\/news\/medical-devices-insights\/\" class=\"category-medical-devices-insights\">Dispositivos m\u00e9dicos<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-ai-drug-regulation-guidance\/\" class=\"plain\" aria-label=\"La FDA de EE. UU. anuncia un borrador de gu\u00eda sobre el uso de IA en...\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"La FDA de EE. UU. anuncia un borrador de gu\u00eda sobre la toma de decisiones regulatorias para el uso de IA en productos biol\u00f3gicos\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">22 de enero de 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/news\/\">Noticias regulatorias<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-ai-drug-regulation-guidance\/\" class=\"plain\">La FDA de EE. UU. anuncia un borrador de gu\u00eda sobre el uso de IA en...<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tEl 6 de enero de 2025, la Administraci\u00f3n de Alimentos y Medicamentos de los Estados Unidos (FDA) anunci\u00f3 la publicaci\u00f3n de un borrador de gu\u00eda titulado \u201cConsideraciones para la\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-ai-drug-regulation-guidance\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Estados Unidos<\/a> <a href=\"https:\/\/regask.com\/es\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Farmacia y biotecnolog\u00eda<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-pediatric-drug-meeting\/\" class=\"plain\" aria-label=\"La FDA de EE. UU. anuncia una reuni\u00f3n p\u00fablica sobre legislaci\u00f3n pedi\u00e1trica\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"La FDA de EE. UU. anuncia una reuni\u00f3n p\u00fablica sobre el impacto de la legislaci\u00f3n pedi\u00e1trica en el desarrollo de medicamentos biol\u00f3gicos para ni\u00f1os\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">8 de enero de 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/news\/\">Noticias regulatorias<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-pediatric-drug-meeting\/\" class=\"plain\">La FDA de EE. UU. anuncia una reuni\u00f3n p\u00fablica sobre legislaci\u00f3n pedi\u00e1trica\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tLa Administraci\u00f3n de Alimentos y Medicamentos (FDA) ha programado una reuni\u00f3n p\u00fablica titulada \u201cReuni\u00f3n de partes interesadas: Implementaci\u00f3n de las mejores pr\u00e1cticas farmac\u00e9uticas\u201d\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-pediatric-drug-meeting\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Estados Unidos<\/a> <a href=\"https:\/\/regask.com\/es\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Farmacia y biotecnolog\u00eda<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-real-world-evidence-center\/\" class=\"plain\" aria-label=\"La FDA (EE. UU.) establece un nuevo centro para la evidencia del mundo real\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"La FDA de Estados Unidos crea un nuevo centro de pruebas del mundo real para mejorar la innovaci\u00f3n, la seguridad y la eficacia de los medicamentos\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">20 de diciembre de 2024 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/news\/\">Noticias regulatorias<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-real-world-evidence-center\/\" class=\"plain\">La FDA (EE. UU.) establece un nuevo centro para la evidencia del mundo real\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tEl 12 de diciembre de 2024, la Administraci\u00f3n de Alimentos y Medicamentos de Estados Unidos (FDA) anunci\u00f3 la creaci\u00f3n del Centro de Evidencia e Innovaci\u00f3n del Mundo Real\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-real-world-evidence-center\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Estados Unidos<\/a> <a href=\"https:\/\/regask.com\/es\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Farmacia y biotecnolog\u00eda<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/portuguese-industry-us-alcohol-labels\/\" class=\"plain\" aria-label=\"La industria portuguesa se opone a la propuesta estadounidense de\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"La industria portuguesa se opone a la propuesta estadounidense de etiquetar las bebidas alcoh\u00f3licas con advertencias sobre el c\u00e1ncer\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">28 de enero de 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/news\/\">Noticias regulatorias<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/portuguese-industry-us-alcohol-labels\/\" class=\"plain\">La industria portuguesa se opone a la propuesta estadounidense de\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tLa Autoridad de Salud de los Estados Unidos est\u00e1 considerando la introducci\u00f3n de etiquetas de advertencia obligatorias sobre c\u00e1ncer en las bebidas alcoh\u00f3licas, una medida similar\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/portuguese-industry-us-alcohol-labels\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Farmacia y biotecnolog\u00eda<\/a> <a href=\"https:\/\/regask.com\/es\/category\/region\/europe\/portugal-regulations\/\" class=\"category-portugal-regulations\">Portugal<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><\/div>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1787608320 > .col-inner {\n  margin: 0px 0px 80px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1382188671 {\n  padding-top: 0px;\n  padding-bottom: 0px;\n}\n<\/style>\n\t<\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":32,"featured_media":8083,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-transparent-header.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-8247","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>RAPS Euro Convergence 2025 | RegASK<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/raps-convergencia-euro-2025\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RAPS Euro Convergence 2025\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/raps-convergencia-euro-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-05T02:15:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png\" \/>\n\t<meta property=\"og:image:width\" content=\"720\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/raps-euro-convergence-2025\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/raps-euro-convergence-2025\\\/\",\"name\":\"RAPS Euro Convergence 2025 | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/raps-euro-convergence-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/raps-euro-convergence-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/RegASK-RAPS.png\",\"datePublished\":\"2025-05-02T09:49:32+00:00\",\"dateModified\":\"2025-05-05T02:15:36+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/raps-euro-convergence-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/raps-euro-convergence-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/RegASK-RAPS.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/RegASK-RAPS.png\",\"width\":720,\"height\":720,\"caption\":\"Regask Raps\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Convergencia RAPS Euro 2025 | RegASK","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/raps-convergencia-euro-2025\/","og_locale":"es_ES","og_type":"article","og_title":"RAPS Euro Convergence 2025","og_url":"https:\/\/regask.com\/es\/raps-convergencia-euro-2025\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_modified_time":"2025-05-05T02:15:36+00:00","og_image":[{"width":720,"height":720,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@ASKRegASK","twitter_misc":{"Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/regask.com\/raps-euro-convergence-2025\/","url":"https:\/\/regask.com\/raps-euro-convergence-2025\/","name":"Convergencia RAPS Euro 2025 | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/raps-euro-convergence-2025\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/raps-euro-convergence-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png","datePublished":"2025-05-02T09:49:32+00:00","dateModified":"2025-05-05T02:15:36+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/raps-euro-convergence-2025\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/raps-euro-convergence-2025\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png","width":720,"height":720,"caption":"Regask Raps"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"El sistema operativo de IA regulatoria para equipos de alto rendimiento","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/pages\/8247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=8247"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/pages\/8247\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/8083"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=8247"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}